IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres (IDIS)

The IDIS study aims to develop a new rapid diagnostic test for invasive salmonellosis using samples (blood, urine) collected from patients with fever and healthy controls at the Institute of Tropical Medicine (ITM) and collaborating centers. The samples are collected after informed consent and/or assent is given by the participant and are stored in a -80 ⁰C freezer after processing (centrifugation and/or aliquoting). Basic information regarding the patient and the samples are coded and stored in a protected Microsoft Access database. The samples will be shipped to Belgium for proteomic analysis. Identification of Salmonella specific proteins in the samples will hopefully support the development of a rapid diagnostic test. Once this test has been developed, the samples will also be used for validation and evaluation of this test.

Study Overview

• Status: Completed
• Conditions: Fever; Salmonella Infections; Blood Stream Infections; Salmonella Septicemia; Parasitic Infections
• Intervention / Treatment: Other: Blood sampling

Detailed Description

The aim of the project is the identification of Salmonella specific proteins that can be detected in samples derived from the host (= humans) during an acute infection. This can support the development of rapid tests to improve the diagnosis of invasive Salmonellosis.

The study is taking place at the travel clinic of the Institute of Tropical Medicine in Antwerp, Belgium, and at the Sihanouk Hospital Center of HOPE in Phnom Penh, Cambodia. It is planned to start in 2016 at the Centre Hospitalier de Kingasani in Kinshasa, Democratic Republic of the Congo in collaboration with the Institut National de Recherche Biomédicale in Kinshasa, Democratic Republic of the Congo. The expected number of participants in total is 2500.

Patients (children and/or adults) presenting with (a history of) fever are asked permission (informed consent and/or assent) to draw additional blood samples (along with routine care samples, so no need for additional venipuncture), and for the long term storage of these samples (whole blood and plasma) in a freezer together with left-over serum and urine samples. They are also asked permission for the collection of coded data including basic demographic, clinical and laboratory data.

Blood for plasma and urine are centrifugated. All samples are aliquoted into cryotubes (coded labelling) before storage in a -80 ⁰C freezer.

Depending on the final diagnosis, patients can be divided in 4 groups:

1. Patients for whom blood cultures grew Salmonella species
2. Patients for whom blood cultures did not grow a pathogen
3. Patients for whom blood cultures grew with another pathogen
4. Healthy controls

The frozen samples collected in Cambodia and the Democratic Republic of the Congo will be shipped to Belgium.

All selection of all the samples collected will undergo proteomic analysis by researchers of the Institute of Tropical Medicine in collaboration with the Vlaams Instituut voor Biotechnologie and coded data related to the samples is shared with these partners.

Once this test has been developed, the samples will also be used for validation and evaluation of this test.

• Study Type: Observational
• Enrollment (Anticipated): 2500

Contacts and Locations

Study Locations

• Belgium
  • Flandres
    • Antwerp, Flandres, Belgium, 2000
      • Institute of Tropical Medicine
• Cambodia
  • Phnom Penh, Cambodia
    • Sihanouk Hospital Center of Hope (SHCH)
• Congo, The Democratic Republic of the
  • Kinshasa, Congo, The Democratic Republic of the
    • Institut National de Recherche Biomedicale

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 2 months and older (Child, Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Children and adults presenting with (a history of) fever and healthy volunteers.

Description

A. Travel clinic Institute of Tropical Medicine (ITM) Antwerp

Inclusion Criteria:

Adults (≥ 18 years) and children aged 3 years to 18 years with (suspicion of) fever and:

1. presenting at ITM travel clinic with history of fever (axillary T° ≥ 38°C) and/or chills/rigor and sweats within 3 days prior to consultation
2. presenting at ITM travel clinic for routine check-up ("apparently healthy")
3. with recent (< 2 weeks) stay in tropical country

Exclusion Criteria:

Refusal to participate

B. Sihanouk Hospital Center of HOPE (SHCH)

Inclusion Criteria:

Adults (≥ 18 years) with (suspicion of) fever and:

1. Presenting at the in- and outpatient department of SHCH with a history of fever (axillary T≥ 38°C) and/or/chills/rigor and sweats within 3 days prior to consultation

Exclusion Criteria:

1. Refusal to participate
2. Not able to give informed consent

Inclusion Criteria:

Adults (≥ 18 years) and children aged 2 months to 18 years with (suspicion of) fever and:

1. Blood culture request by treating physician

Exclusion Criteria:

1. Not able or willing to give informed consent
2. A hemoglobin level that is considered too low for weight and age

Inclusion Criteria:

Adults (≥ 18 years) and children aged 2 months to 18 years with (suspicion of) fever and:

1. Blood culture request by treating physician

Exclusion Criteria:

1. Not able or willing to give informed consent
2. A hemoglobin level that is considered too low for weight and age

Study Plan

How is the study designed?

Design Details

• Observational Models: Case-Control
• Time Perspectives: Prospective

Number of groups / cohorts

4

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Salmonella; Patients for whom blood cultures grew Salmonella species.	Other: Blood sampling; Blood sampling (Volume depending on age, minimum 2.0 ml, maximum 10.9 ml extra)
No pathogen; Patients for whom blood cultures did not grow a pathogen and no pathogen was detected using other routine care diagnostics (e.g. malaria with the use of a malaria rapid test).	Other: Blood sampling; Blood sampling (Volume depending on age, minimum 2.0 ml, maximum 10.9 ml extra)
Another pathogen; Patients for whom blood cultures grew with another pathogen or a pathogen was detected using other routine care diagnostics (e.g. malaria with the use of malaria rapid test).	Other: Blood sampling; Blood sampling (Volume depending on age, minimum 2.0 ml, maximum 10.9 ml extra)
Healthy controls; Healthy controls. Patients without fever but from whom blood is drawn for another reason (e.g. check of cholesterol).	Other: Blood sampling; Blood sampling (Volume depending on age, minimum 2.0 ml, maximum 10.9 ml extra)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Detection of bacterial proteins through Selected Reaction Monitoring (SRM) measured in the unit m/z	Detection of bacterial proteins in the collected urine and blood samples through Selected Reaction Monitoring (SRM) measured in the unit m/z (whereby m = the atomic mass and z = the charge of the ion)	2 years
Quantification of bacterial proteins measured through Selected Reaction Monitoring (SRM) as ion counts	Quantification of bacterial proteins measured through Selected Reaction Monitoring (SRM) as ion counts in the collected urine and blood samples	2 years
Ranking of detected bacterial proteins based on detection per number of samples and on ion counts	Ranking of detected bacterial proteins based on: Detection of bacterial proteins per number of Salmonella positive and Salmonella negative urine and blood samples; Protein abundance measured as ion counts	2 years
Colorimetric detection of the selected proteins by ELISA measured in the unit optical density	Colorimetric detection of the selected proteins by ELISA measured in the unit optical density (OD) and expressed as percentage present in Salmonella positive and Salmonella negative urine and blood samples	2 years
Integration of the selected proteins into a rapid diagnostic test based on a lateral flow format		4 years
Evaluation of the test expressed as percentage positive in samples	Evaluation of the test on the collected blood and urine samples expressed as percentage positive in Salmonella positive and Salmonella negative samples	4 years

Collaborators and Investigators

• Sponsor: Institute of Tropical Medicine, Belgium
• Collaborators: Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo; Vlaams Instituut voor Biotechnologie; Sihanouk Hospital Center of HOPE
• Investigators: Principal Investigator: Laura Kuijpers, MD, MSc, Institute of Tropical Medicine, Antwerp, Belgium; Principal Investigator: Panha Chung, Sihanouk Hospital Center of HOPE (SHCH), Phnom Penh, Cambodia; Principal Investigator: Ange Landela, MD, Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo

Study record dates

Study Major Dates

• Study Start: September 1, 2014
• Primary Completion (Actual): August 1, 2019
• Study Completion (Actual): August 1, 2019

Study Registration Dates

• First Submitted: January 29, 2016
• First Submitted That Met QC Criteria: February 18, 2016
• First Posted (Estimate): February 23, 2016

Study Record Updates

• Last Update Posted (Actual): February 18, 2020
• Last Update Submitted That Met QC Criteria: February 17, 2020
• Last Verified: February 1, 2020

More Information

Terms related to this study

• Keywords: Proteomics; Rapid Diagnostic Test; Salmonellosis
• Additional Relevant MeSH Terms: Pathologic Processes; Systemic Inflammatory Response Syndrome; Inflammation; Disease Attributes; Gram-Negative Bacterial Infections; Bacterial Infections; Bacterial Infections and Mycoses; Enterobacteriaceae Infections; Sepsis; Infections; Communicable Diseases; Parasitic Diseases; Salmonella Infections
• Other Study ID Numbers: IDIS